or Try an Advanced Search...

    ETF Components for FSZ - First Trust Switzerland AlphaDex Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ABBV A -0.07 3.94
    NVS D -0.07 2.43
    LOGI D -0.08 1.39

    Represented by ETF Holdings

    Keywords: Eye Care Products Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Antibiotics Atopic Dermatitis Audiovisual Autoimmune Disease Biotechnology Blood Cancers Blood Test Chronic Idiopathic Constipation Combination Drugs Communication Products Constipation Contact Lens Contact Lenses
    Industries: Drug Manufacturers - Major Computer Systems

    Recent News for First Trust Switzerland AlphaDex Fund & its Holdings

    Date Stock Title
    Oct 2 ABBV AbbVie: $200 Peak (Rating Downgrade)
    Oct 2 NVS Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
    Oct 2 ABBV AbbVie's Skyrizi And Rinvoq Deserve The Premium Growth Valuation
    Oct 2 ABBV Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing
    Oct 2 ABBV 5 Best Dividend Growth Stocks to Buy in October
    Oct 2 ABBV Blue Shield of California sidesteps PBMs with new Humira biosimilar deal
    Oct 2 ABBV Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
    Oct 1 LOGI Logitech Announces Date for Release of Second Quarter Results for Fiscal Year 2025
    Oct 1 ABBV Should You Buy AbbVie Stock After Recent Parkinson's Study Success?
    Oct 1 NVS US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
    Oct 1 ABBV AbbVie withdraws Exviera from EU market for commercial reasons
    Oct 1 LOGI Is it Time to Buy Logitech Stock at a P/E Multiple of 19.52X?
    Oct 1 NVS Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
    Oct 1 ABBV AbbVie to Host Third-Quarter 2024 Earnings Conference Call
    Sep 30 NVS Top Research Reports for Apple, Tesla & T-Mobile US
    Sep 30 NVS Novartis: Value Continues To Build With Double-Digit Percentage Growth Products
    Sep 30 ABBV AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years
    Sep 30 ABBV AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V
    Sep 30 ABBV Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It?
    Sep 30 NVS Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Defined Switzerland Index. The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in stocks and/or depositary receipts that comprise the index. It, using an "indexing" investment approach, attempts to replicate, before fees and expenses, the performance of the index. The index is designed by S&P to objectively identify and select securities from the S&P Switzerland BMI Index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index S&P Sri Lanka 20 Index (Lkr) Switzerland Index
    Back to the Main FSZ Page...